GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

SOPHiA GENETICS SOPH · USD

Health Care · US listing · 🇺🇸 United States

Compare

7.49

+4.90%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About SOPHiA GENETICS

Its shares trade under the ticker SOPH. It has been listed since 23 July 2021. In the fiscal year to 31 December 2025, it reported revenue of $77.3m and a net loss of $79.0m. At that date it held total assets of $163.5m and shareholders' equity of $47.1m.

SOPHiA GENETICS SA is a healthcare technology company, which engages in the practice of data driven medicine as the standard of care and for life sciences research. The firm offer a cloud-based Software-as-a-Service platform - the SOPHiA DDM, which is data-driven medicine platform enabling insights from disparate, complex datasets to improve diagnosis, treatment, and drug development. The firm has offices in Switzerland, France and the United Kingdom and operates worldwide.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Technology
Listed since
23 Jul 2021
Employees
415
Head office
LA PIECE, CH-1180, ROLLE, V8, 00000
Incorporated in
V8
Classification
Services-Computer Processing & Data Preparation
Filer status
Accelerated filer<br>Emerging growth company

Leadership

Pay as last reported

  • Mr. Troy CoxNon-Executive Independent Chairman of the Board
  • Mr. Ross MukenPresident
  • Dr. Jurgi CamblongChief Executive Officer, Co-Founder, Director, since 2011
  • Mr. George CardozaChief Financial Officer
  • Ms. Manuela Da Silva ValenteChief People Officer
  • Dr. Zhenyu XuChief Scientific Officer
  • Mr. Daan Van WellChief Legal and Compliance Officer
  • Dr. Philippe MenuChief Medical Officer and Chief Product Officer, since 2023
  • Dr. Tomer BerkovitzNon-Executive Independent Director
  • Mr. Jean-Michel CossieryNon-Executive Independent Director
  • Ms. Kathy HibbsNon-Executive Independent Director
  • Mr. Didier HirschNon-Executive Independent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Sophia Genetics SA has several strengths that contribute to its success:

Weaknesses

  • Some weaknesses that Sophia Genetics SA needs to address:

Opportunities

  • There are several opportunities for Sophia Genetics SA to capitalize on:

Threats

  • Sophia Genetics SA faces several threats that may impact its growth:

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.